TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presentato dom 30 ago · 16:45 CESTHot Line 8Tutti gli studi Hot Line →

NEXAF

2026

The Norwegian Exercise in Atrial Fibrillation Trial

In 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.

Risultato

co-primary: (1) total time in atrial fibrillation (burden, %) measured by insertable cardiac monitor over 12 months; (2) AFEQT overall score at 12 months
Differenza assoluta
3,2 punti
NNT
32
Stima dell’effetto

relative reduction45P = 0,016

La differenza assoluta e l’NNT sono derivati dai tassi di eventi.

Riportato inoltre: But the co-primary quality-of-life score did not differ (AFEQT +5.6 vs +4.4; P = 0.43). Fitness rose and resting heart rate fell; total hospitalisations were 37% lower and AF-related hospitalisations 46% lower.

Pubblicazione originale
Sottotema
Exercise
Disegno
multicentre (Trondheim, Bærum/Drammen, Tromsø), open-label, two-arm RCT; 1:1 supervised plus eHealth-based exercise vs usual care; blinded statistical analysis; 12-month follow-up with insertable cardiac monitor
Rilevanza
Importante: uno dei diversi pilastri.
Fonte
Nes BM, et al. Presented at ESC Congress 2026, Hot Line 8, 30 August.

Discussione e critica

Exercise halves the time spent in atrial fibrillation, measured by an implanted monitor rather than by symptoms, the cleanest evidence yet that the arrhythmia itself responds to training. The second co-primary endpoint did not move: patients did not feel better, the same dissociation between rhythm and symptoms that the sham-controlled ablation trial in this session found. Open-label against usual care, 295 patients, and the hospitalisation figures are secondary and unadjusted for multiplicity.